GSK2634673F
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
GlaxoSmithKline
Overview
GSK2634673F is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
GSK2634673F clinical trials
Explore related
Medical disclaimer. This page summarizes research about GSK2634673F for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.